Lifespan on its own carries no fiscal sign and no human one. Nobody wants twenty more years spent ill, dependent or in a bed. What makes added years worth having is that function is added with them, and what makes them affordable to a state is the same thing.
Healthspan is the input. Lifespan is what it hands off to. Measuring only the output tells you nothing about whether it was worth buying.
Three outcomes that look identical
Extend function faster than survival and the window of late-life illness shrinks: fewer years lived in the expensive phase, fiscally positive, and the outcome any longevity programme is designed for. Extend function and survival together and the window is unchanged: no care saving at all, and the pension is paid across every added year. Extend survival faster than function and the window widens: more years of high-cost care and more years of pension, fiscally negative.
The same added years carry opposite signs in those three cases, and all three look identical in every existing national statistic, because life expectancy rises in each of them. Only a measured biological-age trajectory separates them.
The compression ratio, healthspan gained over lifespan gained, is the number that decides which of the three a jurisdiction bought. No existing national statistic can produce it.
Why biological age is the instrument
Biological age gain is the only measured quantity that moves both trajectories at once. Slower biological ageing produces slower functional decline, which is healthspan; it lowers the mortality hazard, which is lifespan. One measurement, two outputs, reported separately and never netted against each other.
It also resolves the timing problem that has kept this category unmeasurable. Healthspan is the leading indicator and lifespan the lagging one. Function is readable in one to two years under protocol. Survival is a thirty-year read: a standard that waits for lifespan evidence publishes its first number decades from now. Biological age is what lets a certified population report a defensible figure early and still be reporting against the same instrument when the mortality data arrives.
What a disclosure must carry
Three figures, each with its confidence range: the healthspan delta, the lifespan delta, and the ratio between them. The first is measurable now, the second accrues over the horizon, and the third is the one a treasury, an insurer or a pension fund actually needs. Producing it is the whole reason a measurement layer is worth chartering rather than merely funding.
